With regard to in vivo studies, genetic deletion of NOX4 globally and specifically in podocytes or administration of a novel NOX1/4 inhibitor (GKT137831) attenuated the development of DN.34, 35, 36. Here, NOX1 is linked to liver dysplastic nodule.